collaboration with BioMed Central, the world-famous open access publisher, we gain this opportunity. Therefore, we hope that, with this new arrangement, the journal will continue to grow in its readership as well as upon its impact within the scientific community that it is trying to reach. Fortunately, the open access journals have become a standard vehicle of publication of the newest achievements of the research in cell and molecular biology. Both the Editorial Team and I, believe that the choice we have made are vital for the future of the journal and that we will be successful in achieving our goal. However, we still need the support of all of you, both our authors and our readers, in this.
With this move towards open access comes also a change in the way that the journal will charge for its services, with the introduction of a single flat-fee as an article processing charge (APC) for successful manuscripts. This is an inevitable part of the process of open access publishing, where the costs associated with an open access format are covered by the APC. We believe that, overall, this charge structure represents a cost-effective publishing route, especially when the wider reach of the open access format will bring manuscripts to the attention of a much larger audience, with a corresponding increase in weighting in the impact factor. On behalf of the Editorial team, I promise that our priority is the quality of research presented by the manuscripts it publishes, its novelty, technical advance and importance in learning molecular mechanisms underlying normal and pathological cell biology. All manuscripts will be treated equally, honestly peer-reviewed and published as soon as they will be accepted. So, we invite you all, as authors, to publish with us.
We trust that our authors will be satisfied with the publication service they receive from our Editorial Office and BioMed Central. It is my strong belief that this alliance will secure the stable progress of the journal and help it make a greater impact in the field of the molecular biology of the cell. I also hope very much that it will continue to provide a friendly vehicle for the publication of important and significant achievements in global research towards progress in learning about how cells function.
Editor-in-Chief, Cellular and Molecular Biology Letters *Sadly, passed away on May 20, 2016
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